trecondi
medac gesellschaft für klinische spezialpräparate mbh - treosulfan - blóðmyndandi stofnfrumnaígræðsla - Æxlishemjandi lyf - treosulfan in combination with fludarabine is indicated as part of conditioning treatment prior to allogeneic haematopoietic stem cell transplantation (allohsct) in adult patients and in paediatric patients older than one month with malignant and non-malignant diseases.
minjuvi
incyte biosciences distribution b.v. - tafasitamab - lymphoma, large b-cell, diffuse - Æxlishemjandi lyf - minjuvi is indicated in combination with lenalidomide followed by minjuvi monotherapy for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) who are not eligible for autologous stem cell transplant (asct).
ampicillin stada stungulyfs-/innrennslisstofn, lausn 1 g
stada nordic aps. - ampicillinum natríum - stungulyfs-/innrennslisstofn, lausn - 1 g
ampicillin stada stungulyfs-/innrennslisstofn, lausn 2 g
stada nordic aps. - ampicillinum natríum - stungulyfs-/innrennslisstofn, lausn - 2 g
azitromicina normon filmuhúðuð tafla 500 mg
laboratorios normon s.a. - azithromycinum díhýdrat - filmuhúðuð tafla - 500 mg
cefuroxim navamedic (cefuroxim villerton) stungulyfsstofn, lausn/dreifa 250 mg
navamedic asa - cefuroximum natríum - stungulyfsstofn, lausn/dreifa - 250 mg
cloxacillin vital pharma nordic stungulyfs-/innrennslisstofn, lausn 2 g
vital pharma nordic aps - cloxacillinum natríum - stungulyfs-/innrennslisstofn, lausn - 2 g
zinacef stungulyfs-/innrennslisstofn, lausn 1,5 g
sandoz a/s - cefuroximum natríum - stungulyfs-/innrennslisstofn, lausn - 1,5 g
zinacef stungulyfs-/innrennslisstofn, lausn 750 mg
sandoz a/s - cefuroximum natríum - stungulyfs-/innrennslisstofn, lausn - 750 mg
azacitidine zentiva stungulyfsstofn, dreifa 25 mg/ml
zentiva k.s.* - stungulyfsstofn, dreifa - 25 mg/ml